UNH vs CVS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
UNH · UnitedHealth$394.15 ▼ 0.40%
CVS · CVS Health$83.85 ▲ 3.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- UNH +25.1%
- CVS +10.7%
Head to head
| Metric | UNH | CVS |
|---|---|---|
| Price | $394.15 | $83.85 |
| Change today | ▼ 0.40% | ▲ 3.10% |
| Market cap | $353.17B | $107.28B |
| Return, 3 months | -3.6% | -12.4% |
| Return, year to date | +21.0% | +8.1% |
| Return, 1 year | +24.0% | +8.6% |
| P/E (TTM) | 22.5 | 9.7 |
| P/B | 3.6 | 1.3 |
| P/E percentile vs own 5y | 40th | 67th |
| Dividend yield | 2.30% | 3.17% |
| Revenue growth (YoY, latest qtr) | -0.4% | +7.3% |
| Net profit growth (YoY) | +69.1% | +195.7% |
| Gross margin | 19.8% | 14.2% |
| Operating margin | 5.3% | 3.4% |
| Net margin | 3.5% | 1.2% |
| Return on equity | 15.9% | 6.2% |
| Analyst target vs. price | +22.5% | +32.7% |
| Analyst buy share | 82% | 100% |
| RSI (14) | 46 | 40 |
| 30-day volatility | 27.8% | 47.4% |
| Max drawdown, 1 year | -28.6% | -27.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UNH is the largest of the group by market value.
- UNH has returned the most over the past year.
- CVS carries the lowest trailing P/E.
- CVS pays the highest dividend yield.
- CVS is growing revenue fastest.
- UNH keeps the most profit per dollar of sales.
- UNH has been the calmest stock over the last 30 days.